Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3349607

PASIREOTIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O

Basic Information

ChEMBL ID CHEMBL3349607
Name PASIREOTIDE
Phase Approved
Structure Type BOTH
InChI Key VMZMNAABQBOLAK-DBILLSOUSA-N
Therapeutic ✓ Yes

Known Names

Pasireotida Pasireotide Signifor SOM 230 SOM-230 SOM230
5
Targets
5
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
20
Indications

Molecular Properties

1047.2
MW (Da)

Drug Information

Molecule Type Protein
First Approval 2012
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Natural Product First in Class
USAN Stem -tide
USAN Year 2011

Extended Properties

Molecular Formula C58H66N10O9
MW 1047.23

Indications

Acromegaly Carcinoid Tumor Carcinoid Tumor Pancreatic Neoplasms Pituitary ACTH Hypersecretion ACTH Syndrome, Ectopic Adenoma Adenoma, Islet Cell Breast Neoplasms Carcinoma, Hepatocellular Carcinoma, Medullary Cushing Syndrome Dumping Syndrome Hematologic Neoplasms Hyperglycemia Lung Neoplasms Meningioma Multiple Myeloma Neoplasms Neuroendocrine Tumors

ATC Classification

H01CB05
pasireotide
Level 1: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
Level 2: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES

Activity Summary

Ki 4 meas. best 9.9
IC50 1 meas. best 9.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Somatostatin receptor type 5
CHEMBL1792
Ki 9.9 9.9 0.1 1
Rattus norvegicus
CHEMBL376
IC50 9.4 9.4 0.4 1
Somatostatin receptor type 3
CHEMBL2028
Ki 9.1 9.1 0.8 1
Somatostatin receptor type 2
CHEMBL1804
Ki 9.0 9.0 1.0 1
Somatostatin receptor type 1
CHEMBL1917
Ki 8.2 8.2 6.3 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 6 1
37468498 10.1038/s41467-023-40064-9 Histamine H1 receptor 1
37468498 10.1038/s41467-023-40064-9 Kappa-type opioid receptor 1
37468498 10.1038/s41467-023-40064-9 Substance-K receptor 1
37468498 10.1038/s41467-023-40064-9 D(4) dopamine receptor 1
37468498 10.1038/s41467-023-40064-9 Neuronal acetylcholine receptor subunit alpha-4 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent dopamine transporter 1
37468498 10.1038/s41467-023-40064-9 Beta-2 adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Beta-1 adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Voltage-dependent L-type calcium channel subunit alpha-1C 1
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 7 1
12773038 10.1021/jm021093t Somatostatin receptor type 1 1
37468498 10.1038/s41467-023-40064-9 Voltage-gated inwardly rectifying potassium channel KCNH2 1
37468498 10.1038/s41467-023-40064-9 D(1A) dopamine receptor 1
37468498 10.1038/s41467-023-40064-9 Histamine H2 receptor 1
12773038 10.1021/jm021093t Rattus norvegicus 1
12773038 10.1021/jm021093t Somatostatin receptor type 5 1
12773038 10.1021/jm021093t Somatostatin receptor type 4 1
12773038 10.1021/jm021093t Somatostatin receptor type 3 1

Data from ChEMBL 36 via Core Engine